期刊论文A prospective, parallel group, open-labeled, comparative, multi-centric, active controlled study to evaluate the safety, tolerability and benefits of fixed dose combination of acarbose and metformin versus metformin alone in type 2 diabetes复制

DOI:复制

文献链接: https://pubmed.ncbi.nlm.nih.gov/21510461复制

其他信息:

PMID: 21510461
作者: S Jayaram; R S Hariharan; R Madhavan; I Periyandavar; S S Samra; ...
摘要: Objective: The present study was a prospective, parallel group, open-labeled, comparative, multicentric, active controlled study to evaluate the safety, tolerability and benefits of fixed dose combination of acarbose and metformin versus metformin alone in type 2 diabetic patients.